Can CIPLA be a hedge against rupee depreciation ?

CIPLA is a pharma company that has been listed for a while. The international revenue has been steadily rising, both in absolute value and as a percentage of total revenue. It was 24% for Q4-2019, the last quarter it is at 38%. With a 1.4% depreciation in rupee this quarter, this will increase again. I checked the profit from operating activities and found that the conversion of profits into cash from operations is also high. Am i missing something in this stock ?